Literature DB >> 8733484

High dose rate brachytherapy for the local control of endobronchial carcinoma following external irradiation.

P Hernandez1, A Gursahaney, T Roman, K Schwartzman, D Donath, M G Cosio, R D Levy.   

Abstract

BACKGROUND: External irradiation is an established palliative treatment for patients with inoperable lung cancer. However, persistent or recurrent symptoms due to local disase are common following external irradiation. The impact of high dose rate (HDR) brachytherapy in the palliative management of patients with local sequelae of residual or recurrent endobronchial lung carcinoma following external irradiation was investigated.
METHODS: A prospective cohort of 29 patients (19 men, mean age 65 years) underwent HDR brachytherapy for inoperable lung cancer. All patients had completed external irradiation at least one month before entry into the study (mean (SD) dose 4400 (1481) cGy, completed 12.9 (21.3) months previously). Patients underwent outpatient bronchoscopic placement of 1-3 HDR brachytherapy catheters for delivery of 750-1000 cGy of intraluminal irradiation every two weeks on 1-3 occasions. Prospective evaluation before and four weeks after completion of HDR brachytherapy included assessment of indices of level of function, symptoms, extent of atelectasis (chest radiography), and bronchoscopic determination of degree of endobronchial obstruction.
RESULTS: One hundred and eighteen catheters were placed in 81 treatments. Eleven of the 26 patients who underwent repeat bronchoscopy showed a reduction in the degree of endobronchial obstruction; five of 18 patients had radiographic improvement in the extent of atelectasis. Positive response rates ranged from 25% for signs and symptoms related to pneumonitis to 69% for haemoptysis. Performance status improved in 24% of patients. Two patients died before completion of the study protocol. Short term complications included one episode of non-fatal, massive haemoptysis, five of minor haemoptysis, and one pneumothorax.
CONCLUSIONS: HDR brachytherapy may improve the degree of endobronchial obstruction, atelectasis, symptoms, and level of function with minimal short term complications in patients with recurrent or residual symptomatic disease following external irradiation.

Entities:  

Mesh:

Year:  1996        PMID: 8733484      PMCID: PMC1090667          DOI: 10.1136/thx.51.4.354

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  11 in total

1.  New technique for treating occlusive and stenosing tumours of the trachea and main bronchi: endobronchial irradiation by high dose iridium-192 combined with laser canalisation.

Authors:  H N Macha; K Koch; M Stadler; W Schumacher; D Krumhaar
Journal:  Thorax       Date:  1987-07       Impact factor: 9.139

Review 2.  A new international staging system for lung cancer.

Authors:  C F Mountain
Journal:  Chest       Date:  1986-04       Impact factor: 9.410

3.  The response of atelectasis from lung cancer to radiation therapy.

Authors:  O A Majid; S Lee; S Khushalani; H G Seydel
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-02       Impact factor: 7.038

4.  Intraluminal irradiation for the palliation of lung cancer with the high dose rate micro-Selectron.

Authors:  P A Burt; B R O'Driscoll; H M Notley; P V Barber; R Stout
Journal:  Thorax       Date:  1990-10       Impact factor: 9.139

5.  Radiation bronchitis and stenosis secondary to high dose rate endobronchial irradiation.

Authors:  B L Speiser; L Spratling
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-03-15       Impact factor: 7.038

6.  High dose-rate intraluminal irradiation in bronchogenic carcinoma. Technique and results.

Authors:  D Nori; R Allison; B Kaplan; E Samala; A Osian; S Karbowitz
Journal:  Chest       Date:  1993-10       Impact factor: 9.410

7.  High dose rate intraluminal irradiation in recurrent endobronchial carcinoma.

Authors:  S L Seagren; J H Harrell; R A Horn
Journal:  Chest       Date:  1985-12       Impact factor: 9.410

8.  Remote afterloading brachytherapy for the local control of endobronchial carcinoma.

Authors:  B L Speiser; L Spratling
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-03-15       Impact factor: 7.038

9.  Effect of radiation therapy on bronchial obstruction due to bronchogenic carcinoma.

Authors:  K G Chetty; E M Moran; C S Sassoon; T Viravathana; R W Light
Journal:  Chest       Date:  1989-03       Impact factor: 9.410

10.  Effect of endobronchial radiation therapy on malignant bronchial obstruction.

Authors:  M Mehta; S Shahabi; N Jarjour; M Steinmetz; S Kubsad
Journal:  Chest       Date:  1990-03       Impact factor: 9.410

View more
  2 in total

Review 1.  Lung cancer 5: state of the art radiotherapy for lung cancer.

Authors:  A Price
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

2.  High dose rate endobronchial brachytherapy for the treatment of lung cancer: current status and indications.

Authors:  P Barber; R Stout
Journal:  Thorax       Date:  1996-04       Impact factor: 9.139

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.